Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
After finishing at $7.53 in the prior trading day, Anavex Life Sciences Corporation (NASDAQ: AVXL) closed at $7.37, down -2.12%. In other words, the price has decreased by -$2.12 from its previous closing price. On the day, 0.82 million shares were traded.
Ratios:
Our goal is to gain a better understanding of AVXL by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 6.74 and its Current Ratio is at 6.74. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Cantor Fitzgerald on December 06, 2022, Downgraded its rating to Neutral and sets its target price to $11 from $16 previously.
On June 23, 2022, Berenberg started tracking the stock assigning a Buy rating and target price of $40.
On September 23, 2021, BTIG Research started tracking the stock assigning a Buy rating and target price of $35.BTIG Research initiated its Buy rating on September 23, 2021, with a $35 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jun 14 ’24 when Donhauser Peter D.O. bought 2,835 shares for $3.64 per share. The transaction valued at 10,319 led to the insider holds 5,000 shares of the business.
Stock Price History:
Over the past 52 weeks, AVXL has reached a high of $14.44, while it has fallen to a 52-week low of $3.51. The 50-Day Moving Average of the stock is -15.88%, while the 200-Day Moving Average is calculated to be -8.35%.
Shares Statistics:
A total of 85.33M shares are outstanding, with a floating share count of 82.55M. Insiders hold about 3.30% of the company’s shares, while institutions hold 36.95% stake in the company.
